1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - In July 2025, the M1 year - on - year growth rate was stronger than expected, but the endogenous economic momentum still needs to be strengthened. The rebound of M1 growth rate and the improvement of credit structure release positive signals, yet problems such as weak household credit and reliance on government bonds still exist. In the second half of the year, the growth rate of social financing stock may slow down, while the year - on - year improvement trend of M1 is expected to continue [6][26]. - The growth of social financing mainly depends on government bond issuance, and the growth rate of social financing may reach its peak this year. The support of government bonds for social financing is weakening, and the subsequent growth momentum of social financing needs to focus on the substantial improvement of real - entity financing demand [5][13]. - The recent bond market is under phased pressure. The biggest risk point in the bond market is the strengthening of the equity market. If the equity market stabilizes at key points, it may continue to have a negative impact on the bond market [8][30]. 3. Summary by Relevant Catalogs 3.1 Financial Data Review - **Social Financing**: In July 2025, the new social financing scale was 116 billion yuan, with government bond financing accounting for 107.24%. The year - on - year growth rate of social financing stock was 8.98%, and the social financing growth rate after excluding government bonds was 6.02%. The issuance of special bonds this year is significantly ahead of schedule. As the peak of special bond issuance passes, its support for social financing weakens, and the growth rate of social financing stock may be peaking [5][13]. - **Money Supply**: The year - on - year growth rate of M1 rebounded to 5.60%, mainly driven by the extremely low base effect of corporate current deposits in July 2024. The improvement trend of M1 year - on - year is expected to continue until September due to the low - base effect [5][19]. - **Credit**: New RMB loans were - 5 billion yuan, mainly relying on bill financing. The bill rediscount rate of state - owned joint - stock banks has been declining. The weak credit performance in July is due to the seasonal off - peak of credit and the impact of the revised "Regulations on Guaranteeing the Payment of Payments to Small and Medium - sized Enterprises" [5][22]. 3.2 Financial Data and Bond Market Outlook - **Leading Relationship**: The HP filtering cycle analysis shows that the year - on - year growth rate of M1 leads the Treasury bond yield by about 6 months. However, the recent rebound of M1 is mainly driven by the low - base effect, which may weaken the predictive power of this leading relationship [7][27]. - **Bond Market Situation**: The bond market is under phased pressure due to factors such as the strengthening of M1 data, the improvement of market risk appetite, and policy expectations. The current biggest risk in the bond market is the strengthening of the equity market, and the yield of ten - year Treasury bonds has risen from 1.65% to around 1.70% [8][30].

Investment Rating - The report assigns a "Buy" rating for the company, Jintian Co., Ltd. (金田股份) [4] Core Viewpoints - Jintian Co., Ltd. is the largest producer of copper and copper alloy materials globally, with a comprehensive industrial chain from smelting to deep processing. The company is expected to benefit from the rapid growth in demand for high-end copper products driven by trends in industrial and consumer sectors such as AI data centers and electric vehicles [4][10] - The company is positioned to capture new growth opportunities through its high-end, international, and green product offerings, establishing partnerships with leading brands [4][10] - The report anticipates that the company's profitability will improve due to a stable processing fee rate and a strong pricing power for high-value products, despite fluctuations in copper prices [4][32] Summary by Sections 1. Company Overview - Jintian Co., Ltd. has established itself as a global leader in the copper processing industry, with multiple production bases in China and Vietnam, and a total copper processing capacity expected to reach 2.2 million tons by 2024 [4][10][11] - The company has diversified its product offerings to include rare earth permanent magnetic materials, contributing to its growth strategy [10][11] 2. Historical Growth and Profitability - The company's revenue growth has primarily been driven by the expansion of its copper processing capacity, with a compound annual growth rate (CAGR) of 12.8% from 2017 to 2024 [21] - The processing fee model, which is based on copper prices plus processing fees, provides a stable revenue stream, making the company's profitability less sensitive to copper price fluctuations [18][21] 3. Emerging Industry Demand - The demand for copper is expected to grow significantly in emerging industries such as renewable energy, AI, and robotics, with structural changes in consumption patterns favoring high-end copper products [43][47] - The report highlights that the copper processing industry is moving away from price competition towards consolidation, benefiting leading companies like Jintian Co., Ltd. [43] 4. Financial Projections - The company is projected to achieve revenues of 134.68 billion yuan, 143.46 billion yuan, and 153.59 billion yuan for the years 2025 to 2027, with corresponding net profits of 7.11 billion yuan, 9.99 billion yuan, and 11.86 billion yuan [2][4] - The earnings per share (EPS) are expected to increase from 0.48 yuan in 2025 to 0.80 yuan in 2027, reflecting a positive growth trajectory [2][4]

Investment Rating - The report rates the electronic industry as "stronger than the market" [1]. Core Insights - The semiconductor industry is experiencing an explosive growth phase driven by AI, marking a significant shift from previous cycles driven by consumer electronics [4]. - The demand for advanced processes is expected to surpass that of mature processes, indicating a reversal of the traditional pyramid structure in semiconductor manufacturing [4]. - The report identifies three main trends in semiconductor process development: density enhancement, 2.5D and 3D packaging technologies, and system-level optimization [4]. Summary by Sections Industry Overview - The semiconductor industry is undergoing a transformation characterized by asymmetric growth, where AI-related sectors are seeing explosive demand while traditional sectors are in a digestion phase [4]. - Concerns about the sustainability of AI-driven demand have diminished as major international clients begin to implement AI solutions [4]. Market Trends - Advanced processes are becoming more critical, with the market share of advanced processes expected to exceed that of mature processes [4]. - The report highlights the importance of energy efficiency in advanced processes, with examples showing significant power savings from newer technologies [4]. Investment Recommendations - The report suggests that the current AI-driven semiconductor boom is comparable to an industrial revolution, with a growing gap between market demand and supply chain capacity [4]. - Long-term investment opportunities are identified in advanced equipment, materials, manufacturing, and packaging within the semiconductor sector [4].

Investment Rating - The report maintains a "Strong Outperform" rating for the pharmaceutical sector, indicating a positive outlook compared to the broader market indices [2][4]. Core Insights - The pharmaceutical sector continues to adjust and has underperformed the CSI 300 index, with a weekly decline of 0.84% compared to the index's increase of 1.23% [2]. - The report highlights the recent performance of various sectors, noting that the pharmaceutical sector ranks last among 31 sectors [2]. - The report emphasizes the potential of the brain-computer interface (BCI) industry, supported by recent government policies aimed at fostering innovation and development [2]. - The efficacy of Eli Lilly's oral weight loss drug, Orforglipron, was below market expectations, which opens opportunities for Chinese innovative weight loss drugs in the global market [2]. Summary by Sections Market Performance - The SW Pharmaceutical Index decreased by 0.84% this week, ranking 31 out of 31 sectors, while the CSI 300 index rose by 1.23% [2]. - The report notes that sectors such as defense, non-ferrous metals, and machinery outperformed the pharmaceutical sector [2]. Brain-Computer Interface (BCI) Development - A joint policy from seven government departments aims to promote the BCI industry, targeting breakthroughs in key technologies by 2027 and establishing a competitive industry ecosystem by 2030 [2]. - Companies actively involved in BCI technology development, such as Ruimaite and Chengyitong, are highlighted as potential investment opportunities [2]. Weight Loss Drug Market - Eli Lilly's Orforglipron showed a weight loss of 12.4% after 72 weeks, which is significantly lower than the 17.4% weight loss from a competitor's product [2]. - The report suggests that this underperformance may provide a competitive edge for Chinese companies developing similar drugs, with several already in late-stage clinical trials [2]. Investment Strategy - The report recommends focusing on core sectors with potential for business development (BD) and international expansion, particularly in ADC and PD-1 dual antibodies [2]. - It suggests monitoring high-growth companies in the CXO sector and medical devices, as well as those involved in BCI and AI in healthcare [2].

Investment Rating - The report rates the electronic industry as "Outperform" compared to the market [1]. Core Insights - The electronic industry index increased by 0.28% over the week, outperforming the Shanghai Composite Index, which decreased by 1.75% [2]. - The report highlights the significant advancements in Huawei's Ascend series, particularly the launch of the Ascend 910C CloudMatrix 384 at WAIC 2025, showcasing its high bandwidth and low latency capabilities [5][6]. - The report suggests focusing on domestic semiconductor foundry companies like SMIC and optical module companies like Zhongji Xuchuang, which are expected to benefit from the growing demand for AI computing infrastructure [8][20]. Summary by Sections 1. Industry Performance - The SW electronic industry index ranked 4th out of 31 sectors, with the top five performing sectors being pharmaceuticals (+2.95%), communications (+2.54%), media (+1.13%), electronics (+0.28%), and social services (+0.10%) [2][34]. - The top three sub-sectors within the electronic industry were printed circuit boards (+9.65%), analog chip design (+1.83%), and discrete devices (+1.73%) [2][37]. 2. Huawei's Ascend Series Development - Huawei's Ascend series has seen continuous breakthroughs since the launch of the Ascend 910 chip in 2018, with significant performance improvements in subsequent models [6][11]. - The Ascend 910C, launched in 2025, supports trillion-parameter model training and features a memory bandwidth exceeding 3TB/s [6][12]. 3. Technological Advancements - The Ascend 384 SuperNode architecture utilizes a peer-to-peer bus to interconnect 384 NPUs and 192 Kunpeng CPUs, achieving a one-way bandwidth of 392GB/s and a latency of less than 1 microsecond [7][12]. - Compared to NVIDIA's GB200 NVL72, the Ascend 910C demonstrates superior system-level performance, with a BF16 computing power of 300 PFLOPs and a memory capacity of 49.2TB [19]. 4. Investment Recommendations - The report recommends monitoring SMIC and Zhongji Xuchuang as they are positioned to benefit from the domestic semiconductor and optical module markets, respectively [8][21]. - SMIC is advancing its 7nm process technology, while Zhongji Xuchuang leads the global market in optical modules, expected to see increased sales of high-end products [20][21].

Investment Rating - The report rates the pharmaceutical and biotechnology industry as "stronger than the market" [1]. Core Insights - The pharmaceutical sector has outperformed the CSI 300 index, with a weekly increase of 2.95% compared to a decline of 1.75% for the index. The focus remains on innovative drugs, which continue to attract significant market interest [5][6]. - The SW Pharmaceutical Biotechnology Index has seen a cumulative increase of 22.96% year-to-date, while the Hang Seng Biotechnology Index has surged by 87.68% [2][13]. - The report highlights the ongoing trend of Chinese innovative drugs entering international markets, with significant upcoming scientific conferences expected to showcase new research and facilitate business development (BD) transactions [2][15]. Summary by Sections Market Review - The pharmaceutical sector has shown resilience, ranking first among 31 sectors during the week of July 28 to August 3, with notable performances from innovative drug companies [5][6]. - Key players like Hengrui and GSK have engaged in substantial collaborations, with a deal worth up to $12 billion [38][39]. Investment Strategy - The report suggests focusing on core sectors with potential for business development, particularly ADCs and PD-1 bispecific antibodies. Companies like Maiwei Biotech and Yiming Oncology are highlighted for their promising pipelines [15][17]. - The report emphasizes the importance of monitoring mid-year earnings reports from high-growth companies in the CXO and medical device sectors [15]. Company Highlights - **基石药业 (KeyStone Pharmaceuticals)**: Plans to present clinical data for its PD-1 tri-antibody CS2009 at the ESMO 2025 conference, which is expected to demonstrate superior efficacy compared to existing treatments [18][19]. - **维立志博 (Vilaizhibo)**: Successfully listed on the Hong Kong Stock Exchange, with its PD-L1/4-1BB bispecific antibody LBL-024 showing promising clinical results [26][30]. - **宜明昂科 (Yiming Oncology)**: Reported positive data for its PD-L1/VEGF bispecific antibody IMM2510 in treating non-small cell lung cancer, achieving an overall response rate of 62% [34][35]. - **中国生物制药 (China Biopharmaceutical)**: Anticipates receiving a $300 million milestone payment for its LM-299 project, indicating strong progress in its collaboration with Merck [36]. Industry Dynamics - The report notes that all sub-sectors within the pharmaceutical industry have outperformed the CSI 300 index, with chemical preparations and other biological products leading the gains [6]. - The innovative drug sector remains a focal point, with significant interest in the development of new therapies and collaborations with multinational corporations [2][40].

Investment Rating - The report rates the food and beverage industry as "stronger than the market" [2][5]. Core Insights - The food and beverage sector experienced a decline of 2.17% in the week of July 28 to August 1, underperforming the Shanghai Composite Index, which fell by 0.94% [8]. - The industry is currently at a historical low valuation, with a PE-TTM of 20.95x, placing it in the 16th percentile over the past 15 years [15][19]. - The introduction of the "Childcare Subsidy Policy" is expected to benefit the dairy sector, particularly infant formula, by stimulating consumption among over 20 million families [31]. - The white liquor segment is showing signs of bottoming out, with high-end light bottle liquor expected to be a growth area due to its strong repurchase rate and stable profit margins [26][24]. - The soft drink sector is entering a peak season, with a projected continuation of high growth due to new product launches and a favorable market environment [33]. Summary by Sections 1. Industry Performance - The food and beverage industry index fell by 2.17%, ranking 17th among 31 sub-industries [8]. - The sub-sectors with the least to most decline include: meat products (-0.03%), dairy products (-0.55%), health products (-1.11%), and soft drinks (-4.28%) [10][12]. 2. White Liquor - The white liquor industry is in a phase of stabilization, with high-end light bottle liquor showing strong growth potential [23]. - The anticipated investment of 1.2 trillion yuan in the Yajiang hydropower project is expected to stimulate long-term consumption in the white liquor sector [24]. - Major brands are increasing dividends, with the overall dividend yield in the white liquor sector exceeding 4% [3]. 3. Dairy Products - The newly implemented childcare subsidy policy is projected to directly boost dairy product consumption, especially infant formula [31]. - Companies like Beingmate and Sunshine Dairy have seen significant stock price increases following the announcement of the subsidy [4]. 4. Soft Drinks - The beverage industry has shown strong performance, with a 3.2% year-on-year increase in production in June 2025 [32]. - The sector is expected to maintain high growth due to the introduction of new products and the ongoing peak season [33]. 5. Cost Indicators - Sugar prices remained stable, while prices for soybeans, corrugated paper, and glass saw slight increases [36].

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - From July 28 to August 1, treasury bond yields first rose and then fell due to multiple factors, with the yield curve showing a flattening trend. The resumption of VAT on bonds has a limited negative impact on the bond market, and credit bonds may see value re - evaluation opportunities. The tax advantage of public funds over bank self - operations is further enhanced, which may drive the outsourcing demand of bank self - operations. Next week, fund rates are expected to remain stable, while the supply pressure of treasury bonds will increase. The current bond market strategy suggests maintaining a defensive stance and seizing structural opportunities [2][3][7]. 3. Summary According to the Directory 3.1 Bond Market Weekly Review - From July 28 to August 1, treasury bond yields first rose and then fell. The fund - side was first loose and then tight, remaining generally loose. Important policy events were successively implemented, and the manufacturing PMI in July fell below the boom - bust line. Overall, yields of treasury bonds across various maturities generally declined. For example, the yields of 1 - year, 10 - year, and 30 - year treasury bonds decreased by 1.01BP, 2.65BP, and 2.35BP respectively, and the yield curve showed a flattening trend [2][12]. 3.2 Bond Market Data Tracking 3.2.1 Fund - side - From July 28 to August 1, the central bank's open - market operations had a net injection of 69.00 billion yuan. The central bank conducted 16,632.00 billion yuan of open - market reverse repurchases, with 16,563.00 billion yuan maturing. The fund - side was stable across the month, and the fund rate center declined. The differences in fund costs between non - bank institutions and banks increased, and the term spread of FR007S5Y - FR007S1Y converged [23][24]. 3.2.2 Supply - side - From July 28 to August 1, the total issuance of interest - rate bonds decreased, while the net financing increased. The issuance of government bonds decreased, and the issuance scale of inter - bank certificates of deposit also decreased. The net financing of treasury bonds increased, while that of local government bonds decreased [41][44]. 3.3 Next Week's Outlook and Strategy 3.3.1 Impact of Resuming VAT on the Bond Market - Starting from August 8, 2025, VAT will be resumed on the interest income of newly issued treasury bonds, local government bonds, and financial bonds. This has a limited negative impact on the bond market, and credit bonds may see value re - evaluation opportunities. The tax advantage of public funds over bank self - operations is further enhanced. The market impact after the implementation of the new policy needs to closely track the primary - market issuance [3][52]. 3.3.2 Next Week's Outlook - After crossing the month, fund rates are expected to remain stable. Next week, the planned issuance of treasury bonds is 4130.00 billion yuan, significantly higher than this week, and the supply pressure will increase [59][60]. 3.3.3 Bond Market Strategy - For interest - rate bonds, 10 - year treasury bonds above 1.70% have allocation value, with 1.80% regarded as the upper - limit pressure. For credit bonds, seize the value re - evaluation opportunities brought by the resumption of VAT on interest - rate bonds. In the convertible bond market, focus on equity - balanced varieties. This week, pay attention to the primary - market issuance results of local government bonds on August 8, the central bank's liquidity injection through various tools in July, and inflation data [7][61]. 3.4 Global Major Assets - As of August 1, 2025, yields of US treasury bonds generally declined, and the term spread widened. The US dollar index rose, and the central parity rate of the US dollar against the RMB increased slightly. Gold and crude oil prices rose, while silver prices fell [63][68].

Investment Rating - The mechanical equipment sector is rated as "Outperform" compared to the market, with a ranking of 9 out of 31 in the Shenwan first-level industry classification [4][8]. Core Insights - The report highlights the acceleration of product cost reduction and channel expansion by leading robot manufacturers, with a focus on core component suppliers such as Dechang Motor Holdings, Longsheng Technology, and Zhongdali De [2]. - The high demand for computing power continues, with expectations that the release of high-end computing and storage chips will benefit key equipment companies, suggesting a focus on companies like Tuojing Technology, Shengmei Shanghai, and Beifang Huachuang [2]. - Solid-state batteries are moving towards pilot testing and small-scale production, with equipment companies capable of system integration expected to benefit first from early breakthroughs in the industry, recommending attention to companies like Xian Dao Intelligent and Liyuan Heng [2]. Summary by Sections Weekly Market Review - The mechanical equipment sector experienced a decline of 0.76% this week, while the CSI 300 index fell by 1.75%, with laser equipment being the best-performing sub-sector, increasing by 3.72% [4][8]. - The overall valuation of the mechanical equipment sector decreased by 0.85%, with laser equipment and other specialized automation sectors showing slight increases [15][8]. Company Announcements - China CRRC signed contracts worth 32.9 billion yuan from May to July, representing 13.4% of its projected revenue for 2024 [21]. - Strategic cooperation was established between Taotao Automotive and Yushu Technology to explore overseas markets and C-end scenarios [23][27]. Industry Tracking - The humanoid robot sector is seeing a surge in orders, with significant participation from various companies, including Yushu Technology, which has received approximately 240 million yuan in orders this year [24][26]. - The solid-state battery production is expected to ramp up, with CATL planning small-scale production by 2027 and larger-scale production by 2030 [30][32]. Key Industry Data - The manufacturing PMI for July was reported at 49.3, indicating a contraction in the sector [36]. - The production of industrial robots in June increased by 37.9% year-on-year, while service robots saw an 18.3% increase [52][62].

Investment Rating - The mechanical equipment sector is rated as "Outperform" compared to the market, with a weekly performance of +2.56% against the Shanghai Composite Index's +1.69% [2][12]. Core Insights - The mechanical equipment sector has shown strong performance, particularly in the engineering machinery segment, which increased by +5.91% [2][12]. - The Yarlung Zangbo River downstream hydropower project has commenced, with a planned capacity exceeding 60 million kilowatts and an estimated annual generation of 300 billion kilowatt-hours [26][27]. - The investment intensity of the Yarlung hydropower project is significantly higher than that of the Three Gorges project, indicating a greater demand for advanced equipment due to its complex construction requirements [27][28]. Summary by Sections Weekly Market Review - The mechanical equipment sector outperformed the Shanghai Composite Index with a weekly increase of +2.56% [12]. - The engineering machinery segment led the performance with a +5.91% increase [12][16]. Investment Recommendations - Focus on companies involved in specialized equipment for large-scale engineering projects, such as 铁建重工 (China Railway Construction Heavy Industry), 中铁工业 (China Railway Industry), and 山河智能 (Shanhe Intelligent) [5]. - The humanoid robot sector is recommended for investment due to its high cost-performance ratio and upcoming mid-year reporting period, with a focus on core companies like 拓普集团 (Top Group) and 震裕科技 (Zhenyu Technology) [5]. - Companies in high-end computing and storage chip production, such as 拓荆科技 (Tuojing Technology) and 盛美上海 (Shengmei Shanghai), are expected to benefit from the ongoing demand for key equipment [5]. Hydropower Project Analysis - The Yarlung hydropower project is the largest globally, with a total investment of 1.2 trillion yuan, indicating a high unit investment intensity of 0.28 million USD per megawatt, which is 2.3 times that of the Three Gorges project [27][28]. - The construction phases of traditional hydropower projects involve significant equipment demand, particularly during the peak construction phase [30][31]. Robotics and Automation - The humanoid robot market is accelerating, with companies like 宇树科技 (Unitree Technology) launching new products at competitive prices, indicating a trend towards cost reduction and increased market penetration [39][40]. - 优必选 (UBTECH) has secured a significant order for humanoid robots, highlighting the growing demand in industrial applications [39][40]. Semiconductor and Battery Equipment - Longjiang Storage is set to trial its first fully domestic production line, aiming to double its output and capture a larger market share in NAND flash memory [41]. - Companies like 孚能科技 (Fengneng Technology) and 豪鹏科技 (Haopeng Technology) are advancing in solid-state battery production, with significant improvements in energy density and safety features [42]. Nuclear Fusion - The establishment of the Fusion Energy Group, aimed at accelerating the commercialization of nuclear fusion technology, marks a significant development in the energy sector [43].